What to know about the GLP-1 weight loss drugs
Go Deeper.
Create an account or log in to save stories.
Like this?
Thanks for liking this story! We have added it to a list of your favorite stories.
Drugs like Ozempic and Mounjaro were first developed to treat diabetes.
They turned out to be so effective at helping people lose weight that new versions were approved for weight loss. And now, their use has skyrocketed.
One in every eight American adults has taken what are known as GLP-1 drugs.
They not only lead to health benefits associated with weight loss, like lower risk of heart attack and stroke, they also seem to tame addictive cravings and boost sleep.
MPR News guest host Catharine Richert talks with a doctor and a dietitian about the exploding popularity of GLP-1 drugs, side effects and how to use them responsibly.
Guests:
Dr. Carolyn Bramante is an internal medicine doctor who specializes in obesity and weight loss. She is an assistant professor at the University of Minnesota Medical School and sees adults and children at the M Health Fairview weight management clinic.
Tara Schmidt is a registered dietitian and instructor of nutrition at Mayo Clinic in Rochester, MN. She is the lead dietitian for the Mayo Clinic Diet, host of the podcast “On Nutrition,” and co-authored “The Mayo Clinic Diet: Weight Loss Medications Edition.”
Subscribe to the MPR News with Angela Davis podcast on: Apple Podcasts, Spotify or RSS.
Turn Up Your Support
MPR News helps you turn down the noise and build shared understanding. Turn up your support for this public resource and keep trusted journalism accessible to all.
